Abstract: Systems and methods are provided for predicting treatment-regimen-related outcomes (e.g., risks of regimen-related toxicities). A predictive model is determined for predicting treatment-regimen-related outcomes and applied to a plurality of datasets. An ensemble algorithm is applied on result data generated from the application of the predictive model. Treatment-regimen-related outcomes are predicted using the predictive model. A combination of machine learning prediction and patient preference assessment is provided for enabling informed consent and precise treatment decisions.
Type:
Grant
Filed:
April 16, 2018
Date of Patent:
November 12, 2019
Assignee:
Inform Genomics, Inc.
Inventors:
Ed Rubenstein, Stephen T. Sonis, Carl De Moor